Phastar 's Principal Data Scientist Evgeny Galimov will be presenting at CLAIR 2026 on how AI and self-service approaches can help bridge the gap between research questions and actionable evidence in clinical research.
Public source
Publisher name
Public post
How can AI help turn research questions into evidence faster? That's the topic Phastar's Evgeny Galimov, Principal Data Scientist, will be exploring at CLAIR 2026 with h…
Company
Phastar
Bringing data to life
- Industry
- Biotechnology Research
- Location
- London, GB
- Company size
- 201–500 employees
About Phastar
Phastar is an award-winning specialist biometrics and data science CRO, trusted by pharma, biotech, and medical device companies worldwide. With a global team of data specialists, it brings expertise, precision, and pace to every trial – because behind every data point is a patient waiting for treatment. Phastar doesn’t just deliver high-quality clinical trial data. It partners with clients to turn complexity into clarity. Leveraging technology, AI-enhanced analytics, advanced statistical methods, and deep therapeutic expertise, it accelerates regulatory approvals, ensures compliance with global standards and mitigates risk. Phastar has a proven track record in transforming complex data into clear, actionable intelligence, empowering its partners to accelerate drug development. With scalable, tailored solutions, it expedites trials – bringing life-changing therapies to patients faster.
See moreLatest activity
Latest activity from Phastar
9 signals
Presence & Recognition
Phastar is attending the ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop in Rockville, MD, at Booth #13.
Research & Knowledge
Phastar published a case study detailing how the company designed a Bayesian Phase I/II trial for an emerging biotech preparing for its first-in-human oncology study to support dose escalation, early efficacy assessment, and regulatory acceptance from both the FDA and EMA.
Partnerships
Phastar partnered with an emerging biotech to develop an innovative Bayesian Phase I/II oncology design for a first-in-human clinical trial.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
PhaseV
PhaseV Booth 512 will host a presentation by Hamza Sheikh on accelerating clinical development from synopsis to CSR using a human-guided AI workflow at DPHARM2026 on September 15 at 11:35 a.m. to 11:45 a.m. in Constitution B.
Presence & Recognition
Clymb Clinical
Clymb Clinical is hosting a live walkthrough on September 25th to showcase the Clymbr Hub and its end-to-end biometrics automation and AI workflow solutions for Pharma and Biotech companies.
Presence & Recognition
Genomics
Genomics Chief Scientific Officer Vincent Plagnol will be addressing the central question of AI helping in R&D at the Amazon Web Services AI Symposium in London.
Presence & Recognition
Ardigen
Ardigen will be presenting at BioTechX Europe in Basel, 6-8 October, discussing AI-enabled target discovery and phenotypic profiling.
Presence & Recognition
Phesi